These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19203511)

  • 1. Remission of minimal change disease in Type 2 diabetes after streptococcus bacteremia.
    Enriquez R; Sirvent AE; Padilla S; Andrada E; Amorós F; Fernandez-Lozano JA; Gutiérrez F
    Clin Nephrol; 2009 Feb; 71(2):179-82. PubMed ID: 19203511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal change disease associated with type 1 and type 2 diabetes mellitus.
    Moyses Neto M; Silva GE; Costa RS; Romão EA; Vieira Neto OM; Dantas M
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):331-5. PubMed ID: 22911287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin].
    Makibayashi K; Fukatsu A; Kita T
    Nihon Jinzo Gakkai Shi; 2002 Mar; 44(2):109-13. PubMed ID: 11974950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible minimal change nephrotic syndrome and glomerular IgA deposition associated with nonparenteral heroin abuse: a case report.
    Turgutalp K; Kiykim A; Karabulut U; Gursoy D; Gurses I
    Med Princ Pract; 2012; 21(5):492-4. PubMed ID: 22539034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
    García Donaire JA; Manzanera MI; Valentín MO; Espejo B; Gutiérrez Martínez E; Praga M
    Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pembrolizumab-associated nephrotic syndrome recovered from transient hemodialysis in a patient with lung cancer.
    Ishibuchi K; Iwakura T; Kaneko M; Fukasawa H; Furuya R
    CEN Case Rep; 2020 Aug; 9(3):215-219. PubMed ID: 32170578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation.
    Akar H; Keven K; Celebi H; Orhan D; Nergizoğlu G; Erbay B; Tulunay O; Ozcan M; Ertürk S
    J Nephrol; 2002; 15(1):79-82. PubMed ID: 11936432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotic Syndrome After Hematopoietic Stem Cell Transplant: Outcomes in Iran.
    Saddadi F; Alidadi A; Hakemi M; Bahar B
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):90-92. PubMed ID: 28260442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo minimal change disease after ABO-incompatible kidney transplantation.
    Mochizuki Y; Iwata T; Nishikido M; Uramatsu T; Sakai H; Taguchi T
    Clin Transplant; 2012 Jul; 26 Suppl 24():81-5. PubMed ID: 22747482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
    Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
    Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease.
    Qin J; Yang Q; Tang X; Chen W; Li Z; Mao H; Jiang Z; Huang F; Yu X
    Clin Nephrol; 2013 Jan; 79(1):37-44. PubMed ID: 22948116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic syndrome after insect sting: a case report.
    Junqueira V; Donato B; Teixeira C; Mascarenhas MI; Silva IC; Almeida E
    J Bras Nefrol; 2020; 42(4):498-501. PubMed ID: 32818223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal-change nephrotic syndrome and acute renal failure in a patient with aged onset insulin-dependent diabetes mellitus and autoimmune thyroiditis.
    Kagiyama S; Tsuruta H; Tominaga M; Morishita K; Doi Y; Onoyama K
    Am J Nephrol; 1999; 19(3):369-72. PubMed ID: 10393372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient.
    Hyun JI; Min JW; Lee HM; Kim YK; Choi EJ; Song HC
    Korean J Intern Med; 2017 Jan; 32(1):186-189. PubMed ID: 26951918
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimal change glomerulonephritis associated with hydatid disease.
    Gelman R; Brook G; Green J; Ben-Itzhak O; Nakhoul F
    Clin Nephrol; 2000 Feb; 53(2):152-5. PubMed ID: 10711418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal change disease as the etiology of the nephrotic syndrome in a patient with angioimmunoblastic lymphadenopathy.
    Staszewski H; Kumar G; Mishriki Y
    Med Pediatr Oncol; 1988; 16(3):206-9. PubMed ID: 3380062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoid nephrosis in a child with advanced Hodgkin's lymphoma].
    Gordillo Paniagua G; Velázquez Jones L; Scovino Gudiño R; Arroyo Sierra J; Silva Sosa M; Mota Hernández F
    Bol Med Hosp Infant Mex; 1977; 34(4):815-21. PubMed ID: 911442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal change disease in pregnancy.
    Lo JO; Kerns E; Rueda J; Marshall NE
    J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1282-4. PubMed ID: 24102437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.